Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

We interview Mary Lavin, President of Sartorius North America, about her career.

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.

It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.

Global regulators attended a virtual workshop on second generation COVID-19 vaccines – here’s what they talked about.

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Can a new malaria vaccine hold the key to reliable, durable protection?